Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer (CLERAD-PROBE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01704586
Recruitment Status : Recruiting
First Posted : October 11, 2012
Last Update Posted : November 4, 2020
Deutsche Krebshilfe e.V., Bonn (Germany)
Information provided by (Responsible Party):
Manuel Weber, Dr. med.., University of Wuerzburg

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : November 2025